News & Insights
Sort By
Insights 148 Results
Insights
|March 23, 2026
Gunderson Dettmer life sciences and public companies advisor Brett Pletcher was featured in Cure’s article, "The Legal Playbook for Building a Biotech Company, From Formation to Financing," which discusses how a biotech company’s legal needs shift quickly as it grows and explores how founders can build the right legal foundation, avoid common missteps, and bring in the right counsel at the right time.
Insights
|March 16, 2026
Client Insight: Quarterly Employment Law Update — Winter 2026
This update highlights key legislative and regulatory changes taking effect this winter, noteworthy lawsuits, and recent updates to Gunderson Dettmer’s Contract Generator, with links to deeper-dive resources where relevant
Insights
|February 11, 2026
The deadline for making certain initial, annual and amended securities filings for the year ended December 31, 2025 is Tuesday, February 17, 2026
Events 33 Results
Events
|January 27, 2026
Tim Ehrlich, Chair of Gunderson Dettmer’s Life Sciences practice and host of the “What’s Next in Biotech” series, sits down with Hogan Lovells Partner and former senior FDA official Elizabeth Jungman for a candid conversation about where biotech regulatory pathways stand today and where they are headed next.
Events
|January 22, 2026
Employment & Labor Partner Max Perlman is the chair of MCLE’s upcoming seminar “Employment Law for Business Lawyers & In-House Counsel” and will be presenting on developments in noncompete law and navigating the current Administration’s impact on labor and employment law
Events
|December 11, 2025
Katten and Gunderson Dettmer discusses the SEC’s recent policy statement on mandatory securities arbitration and whether it represents a meaningful shift for companies and their investors
Client News 279 Results
Client News
|May 19, 2026
Gunderson Dettmer Represents Dwolla in its Sale to NMI
Dwolla, one of the best-known account-to-account (A2A) payment infrastructure providers, announces its sale to NMI, a global leader in embedded payments infrastructure.
Client News
|May 14, 2026
Nectar Social Raises $30 Million Series A
Nectar Social announces its $30 million Series A financing led by Menlo Ventures with participation from True Ventures, Google Ventures, and Gwyneth Paltrow’s Kinship Ventures.
Client News
|May 12, 2026
Thrive Capital Leads Isomorphic Labs’ $2.1 Billion Series B
Thrive Capital led the $2.1 billion Series B financing of Isomorphic Labs, an AI-first drug design and development company.
Firm News 109 Results
Firm News
|June 1, 2026
Gunderson Dettmer Commemorates 2026 Pride Month - For All of Us
Gunderson Dettmer is proud to commemorate Pride Month in June 2026. This year, we join NYC Pride’s theme, “For All of Us.”
Firm News
|February 1, 2026
Gunderson Dettmer Commemorates 2026 Black History Month
Gunderson Dettmer commemorates Black History Month in February 2026 with a series of events across its US offices, access to resources, and a tribute to this month’s theme, "A Century of Black History Commemorations."
Blog Posts 36 Results
Public Ventures
|June 1, 2026
‘Dramatic Overreach’ of Authority: SEC Proposes to Rescind Climate Disclosure Rules
“We must re-examine the costs, burdens, and benefits of disclosure mandates to make becoming and remaining a public company more attractive again. SEC disclosure obligations should comply with the Commission’s statutory authority, be guided by materiality as the North Star, avoid the practical effect of dictating corporate behavior, and be imposed only when the expected benefits justify the likely costs and burdens.”
Public Ventures
|May 27, 2026
SEC Chair Announces IPO Modernization Initiative
Public input invited through July 27, 2026 on ways to improve the process and method of becoming a public company
Public Ventures
|May 6, 2026
SEC Proposes Optional Semiannual Financial Reporting Framework for Public Companies
“Today’s proposal is just the first step of the larger, comprehensive effort to review and reshape the current SEC rules governing public companies with respect to their ongoing reporting obligations and their ability to raise capital in the public markets. Over the next few months, I expect that the Commission will be considering a series of proposals that, if adopted, will not only redefine what it means to be a public company, but will make being public attractive again.”